retatrutide glp-1 medication vs Tirzepatide vs Semaglutide Retatrutide vs Tirzepatide (2026): Differences
Description
Our team helps patients make informed choices based on their medical profile
PMID: 18 National Cancer Institute
Less common (tell your doctor): Gallbladder pain, raised heart rate, signs of pancreatitis (rare)
The CBO analysis found that the annual cost to cover these medications would be $5,600 per person on the drug in 2026, decreasing to $4,300 in 2034
